Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Stratigos

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinomaC Dessinioti, A J Stratigos
Journal of the European Academy of Dermatology and Venereology : JEADV|April 13, 2023
Adjuvant treatment in advanced melanoma: How far have we come?V Nikolaou, A J Stratigos
The British Journal of Dermatology|June 19, 2016
Inherited susceptibility to melanoma: insights from a high-risk Austrian cohortI Stefanaki, A J Stratigos
The British Journal of Dermatology|July 3, 2013
Emerging trends in the epidemiology of melanomaV Nikolaou, A J Stratigos
Archives of Dermatology|November 16, 2001
Unraveling the molecular mechanisms of hair and nail genodermatosesA J Stratigos, H P Baden
Clinics in Dermatology|May 23, 2001
Dermatologic therapy in the new millenniumA D Katsambas, A J Stratigos
Clinics in Dermatology|September 6, 2001
Depigmenting and bleaching agents: coping with hyperpigmentationA D Katsambas, A J Stratigos
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2021
The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activitiesC Dessinioti, C Garbe, A J Stratigos
The British Journal of Dermatology|December 21, 2016
Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promiseE Soura, V Chasapi, A J Stratigos
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2021
Epidemiology of advanced cutaneous squamous cell carcinomaC Dessinioti, M Pitoulias, A J Stratigos
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinomaC Dessinioti, A J Stratigos
Journal of the European Academy of Dermatology and Venereology : JEADV|April 13, 2023
Adjuvant treatment in advanced melanoma: How far have we come?V Nikolaou, A J Stratigos
The British Journal of Dermatology|June 19, 2016
Inherited susceptibility to melanoma: insights from a high-risk Austrian cohortI Stefanaki, A J Stratigos
The British Journal of Dermatology|July 3, 2013
Emerging trends in the epidemiology of melanomaV Nikolaou, A J Stratigos
Archives of Dermatology|November 16, 2001
Unraveling the molecular mechanisms of hair and nail genodermatosesA J Stratigos, H P Baden
Clinics in Dermatology|May 23, 2001
Dermatologic therapy in the new millenniumA D Katsambas, A J Stratigos
Clinics in Dermatology|September 6, 2001
Depigmenting and bleaching agents: coping with hyperpigmentationA D Katsambas, A J Stratigos
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2021
The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activitiesC Dessinioti, C Garbe, A J Stratigos
The British Journal of Dermatology|December 21, 2016
Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promiseE Soura, V Chasapi, A J Stratigos
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2021
Epidemiology of advanced cutaneous squamous cell carcinomaC Dessinioti, M Pitoulias, A J Stratigos
Pageof 7